본문 바로가기

Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
피인용
Web of Science 104Scopus 66
FWCI (Scopus)
1.05
JCR IF
JCR 2017 4.936
ISSN
1942-0900

저자

  1. 이수연제1저자Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan, South Korea
  2. 주민경Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan, South Korea
  3. 전현민Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan, South Korea
  4. 이익지Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan, South Korea
  5. Kim, Cho HeeDepartment of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan, South Korea
  6. 박혜경Nanobiotechnology Center, Pusan National University, Pusan, South Korea
  7. Han, Song Iy교신저자Division of Natural Medical Sciences, College of Health Science, Chosun University, Gwangju, South Korea
  8. 강호성Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan, South Korea

초록

Metastasis is a major obstacle to the efficient and successful treatment of cancer. Initiation of metastasis requires epithelial-mesenchymal transition (EMT) that is regulated by several transcription factors, including Snail and ZEB1/2. EMT is closely linked to the acquisition of cancer stem cell (CSC) properties and chemoresistance, which contribute to tumor malignancy. Tumor suppressor p53 inhibits EMT and metastasis by negatively regulating several EMT-inducing transcription factors and regulatory molecules; thus, its inhibition is crucial in EMT, invasion, metastasis, and stemness. Metabolic alterations are another hallmark of cancer. Most cancer cells are more dependent on glycolysis than on mitochondrial oxidative phosphorylation for their energy production, even in the presence of oxygen. Cancer cells enhance other oncogenic metabolic pathways, such as glutamine metabolism, pentose phosphate pathway, and the synthesis of fatty acids and cholesterol. Metabolic reprogramming in cancer is regulated by the activation of oncogenes or loss of tumor suppressors that contribute to tumor progression. Oncogenic metabolism has been recently linked closely with the induction of EMT or CSC phenotypes by the induction of several metabolic enzyme genes. In addition, several transcription factors and molecules involved in EMT or CSCs, including Snail, Dlx-2, HIF-1, STAT3, TGF-, Wnt, and Akt, regulate oncogenic metabolism. Moreover, p53 induces metabolic change by directly regulating several metabolic enzymes. The collective data indicate the importance of oncogenic metabolism in the regulation of EMT, cell invasion and metastasis, and adoption of the CSC phenotype, which all contribute to malignant transformation and tumor development. In this review, we highlight the oncogenic metabolism as a key regulator of EMT and CSC, which is related with tumor progression involving metastasis and chemoresistance. Targeting oncometabolism might be a promising strategy for the development of effective anticancer therapy.

키워드

EPITHELIAL-MESENCHYMAL TRANSITIONPYRUVATE-KINASE M2DNA-DAMAGE MODELINDUCED SENESCENCEGLUCOSE-METABOLISMDOWN-REGULATIONIDH MUTATIONSTUMOR-CELLSTGF-BETAMITOCHONDRIAL DYSFUNCTION

식별자

Scopus EID
2-s2.0-85060365620
WoS UID
000455630200001